Drug-induced cardiomyopathies.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D009202:Cardiomyopathies / Q000139:chemically induced / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003035:Cobalt / Q000506:poisoning; D003520:Cyclophosphamide / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D006321:Heart / Q000033:anatomy & histology; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D006967:Hypersensitivity; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology* / Q000648:ultrastructure
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D003035:Cobalt; D004317:Doxorubicin; D003520:Cyclophosphamide; D003630:Daunorubicin